Skip to main content
Andrew Goldfine, MD, Neurology, Phoenixville, PA

Andrew M. Goldfine MD MA


Medical Director, GSK

Join to View Full Profile
  • 143 Church St,Phoenixville, PA 19460

Dr. Goldfine is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neurorehabilitation, 2007 - 2009
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2003 - 2007
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - Present
  • PA State Medical License
    PA State Medical License 2021 - 2026
  • NJ State Medical License
    NJ State Medical License 2018 - 2023
  • NY State Medical License
    NY State Medical License 2005 - 2018
  • Neurology
    American Board of Psychiatry and Neurology Neurology
  • Neurorehabilitation and Neural Repair
    United Council for Neurologic SubspecialtiesNeurorehabilitation and Neural Repair

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2016-2017
  • CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2016-2017
  • CMS Meaningful Use Stage 1 Certification P2 Sentinel, Cerner Corporation, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

  • Public Health.
    Jonathan Davitte, Usha Gungabissoon, Jessica Chao, Spiros Denaxas, Ian J Douglas
    Alzheimer's & Dementia. 2025-12-01
  • Biomarkers.
    Aya Abdallah, Robert Allen, Dominik Domanski, Andrew M Goldfine, Sanjay Kumar
    Alzheimer's & Dementia. 2025-12-01
  • 11 citations
    Seeking progress in disease modification in Parkinson disease.
    Codrin Lungu, Jesse M. Cedarbaum, Ted M. Dawson, E. Ray Dorsey, Carlos Faraco
    Parkinsonism & Related Disorders. 2021-09-01

Grant Support

  • Mentored Patient-Oriented Research (K23)Eunice Kennedy Shriver National Institute of Child Health & Human Development2014–2017

Industry Relationships

  • Medical Director, Sun Pharmaceuticals2017 - Present

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: